Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023 08:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the...
Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards
August 15, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ is proud to announce its nomination for the...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
August 11, 2023 16:41 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2023 (GLOBE NEWSWIRE) -- August 11, 2023—Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement...
Science 37 Reports Second Quarter 2023 Financial Results
August 08, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...
Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
July 25, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial...
Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
July 11, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ has been chosen by Synlogic, (Nasdaq:...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 07, 2023 16:52 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
June 09, 2023 16:51 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"
May 18, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, has been named the winner of the...
Science 37 Reports First Quarter 2023 Financial Results
May 15, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...